{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:40:03Z","timestamp":1765438803411,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiovascular comorbidities (CVCs) affect the overall survival (OS) of patients with colorectal cancer (CRC). However, a prognostic evaluation system for these patients is currently lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to develop and validate a nomogram, which takes CVCs into account, for predicting the survival of patients with CRC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 21,432 patients with CRC were recruited from four centers in China between January 2011 and December 2017. The nomogram was constructed, based on Cox regression, using a training cohort (19,102 patients), and validated using a validation cohort (2,330 patients). The discrimination and calibration of the model were assessed by the concordance index and calibration curve. The clinical utility of the model was measured by decision curve analysis (DCA). Based on the nomogram, we divided patients into three groups: low, middle, and high risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Independent risk factors selected into our nomogram for OS included age, metastasis, malignant ascites, heart failure, and venous thromboembolism, whereas dyslipidemia was found to be a protective factor. The c-index of our nomogram was 0.714 (95% <jats:italic>CI<\/jats:italic>: 0.708\u20130.720) in the training cohort and 0.742 (95% <jats:italic>CI<\/jats:italic>: 0.725\u20130.759) in the validation cohort. The calibration curve and DCA showed the reliability of the model. The cutoff values of the three groups were 68.19 and 145.44, which were also significant in the validation cohort (<jats:italic>p<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Taking CVCs into account, an easy-to-use nomogram was provided to estimate OS for patients with CRC, improving the prognostic evaluation ability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.875560","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T05:58:29Z","timestamp":1654063109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities"],"prefix":"10.3389","volume":"9","author":[{"given":"Hao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqing","family":"Ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haobo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoxuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?.","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamaoncol.2019.0695","article-title":"Body composition and cardiovascular events in patients with colorectal cancer: a population-based retrospective cohort study.","volume":"5","author":"Brown","year":"2019","journal-title":"JAMA Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2017.74.9739","article-title":"New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer.","volume":"36","author":"Kenzik","year":"2018","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","article-title":"The impact of comorbidity on cancer and its treatment.","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging.","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis.","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC VIII Edition: colorectal cancer.","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of Cardiovascular Diseases in China, 1990-2016: findings from the 2016 global burden of disease study.","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/jjco\/hyz035","article-title":"Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.","volume":"49","author":"Zhang","year":"2019","journal-title":"Jpn J Clin Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jnci\/djx253","article-title":"Personalizing Survival Predictions in Advanced Colorectal Cancer: the ARCAD nomogram project.","volume":"110","author":"Sjoquist","year":"2018","journal-title":"J Natl Cancer Inst."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.3748\/wjg.v21.i41.11877","article-title":"Nomograms for colorectal cancer: a systematic review.","volume":"21","author":"Kawai","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/jso.24774","article-title":"Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes.","volume":"116","author":"Mahar","year":"2017","journal-title":"J Surg Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer.","volume":"383","author":"Brenner","year":"2014","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/cam4.2896","article-title":"Nomogram for predicting overall survival in stage II-III colorectal cancer.","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S1470-2045(17)30336-4","article-title":"Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.","volume":"18","author":"Tseng","year":"2017","journal-title":"Lancet Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11605-019-04441-4","article-title":"Peritoneal Metastases in Colorectal Cancer: biology and barriers.","volume":"24","author":"Xue","year":"2020","journal-title":"J Gastrointest Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/hep.1840080521","article-title":"Ascitic fluid analysis in malignancy-related ascites.","volume":"8","author":"Runyon","year":"1988","journal-title":"Hepatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1007\/s00520-020-05401-4","article-title":"Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.","volume":"28","author":"Nagata","year":"2020","journal-title":"Support Care Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/j.1532-5415.2006.00973.x","article-title":"Multimorbidity and survival in older persons with colorectal cancer.","volume":"54","author":"Gross","year":"2006","journal-title":"J Am Geriatr Soc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1200\/JCO.2011.40.3188","article-title":"Postoperative adjuvant chemotherapy use in patients with stage II\/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.","volume":"31","author":"Khrizman","year":"2013","journal-title":"J Clin Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.6004\/jnccn.2017.7026","article-title":"Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.","volume":"16","author":"Hahn","year":"2018","journal-title":"J Natl Compr Canc Netw."},{"key":"B25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/bjs.4913","article-title":"Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer.","volume":"92","author":"Lemmens","year":"2005","journal-title":"Br J Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland.","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail."},{"key":"B27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/bmj.308.6933.891","article-title":"Deep venous thrombosis and occult malignancy: an epidemiological study.","volume":"308","author":"Nordstr\u00f6m","year":"1994","journal-title":"BMJ."},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00384-017-2909-2","article-title":"Colorectal cancer and thrombosis.","volume":"33","author":"Rees","year":"2018","journal-title":"Int J Colorectal Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1160\/TH05-10-0694","article-title":"Trousseau\u2019s syndrome - what is the evidence? A population-based autopsy study.","volume":"95","author":"Ogren","year":"2006","journal-title":"Thromb Haemost."},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.","volume":"24","author":"Alcalay","year":"2006","journal-title":"J Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis.","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-cancer-associated thrombosis study.","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2017.11.039","article-title":"Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: a systematic review and meta-analysis.","volume":"477","author":"Zhou","year":"2018","journal-title":"Clin Chim Acta."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0976-4","article-title":"Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.","volume":"15","author":"Katzke","year":"2017","journal-title":"BMC Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/cncr.27923","article-title":"Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients.","volume":"119","author":"Yang","year":"2013","journal-title":"Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canep.2018.01.001","article-title":"An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: the FIESTA study.","volume":"52","author":"Peng","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.2010.31.5200","article-title":"Total cholesterol and cancer risk in a large prospective study in Korea.","volume":"29","author":"Kitahara","year":"2011","journal-title":"J Clin Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1227\/01.NEU.0000360130.52812.1D","article-title":"Effect of simvastatin on glioma cell proliferation, migration, and apoptosis.","volume":"65","author":"Wu","year":"2009","journal-title":"Neurosurgery."},{"key":"B41","first-page":"233","article-title":"Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study.","volume":"23","author":"Tomiki","year":"2004","journal-title":"J Exp Clin Cancer Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.3748\/wjg.v20.i26.8646","article-title":"Lipid levels in serum and cancerous tissues of colorectal cancer patients.","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3322\/caac.21339","article-title":"American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.","volume":"66","author":"Kattan","year":"2016","journal-title":"CA Cancer J Clin."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.875560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T05:58:34Z","timestamp":1654063114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.875560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2022.875560"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.875560","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"875560"}}